| NCX3 — Sodium Calcium Exchanger 3 | |
|---|---|
| Symbol | NCX3 |
| Full Name | Sodium Calcium Exchanger 3 |
| Chromosome | 20p13 |
| NCBI Gene | 6578 |
| Ensembl | ENSG00000170088 |
| OMIM | 607858 |
| UniProt | Q9M819 |
| Protein Length | 932 amino acids |
| Molecular Weight | ~108 kDa |
| Diseases | [ALS](/diseases/als), [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Muscular dystrophy |
| Expression | Brain, Skeletal muscle, Heart, Retina |
NCX3 (SLC8A3) encodes the sodium-calcium exchanger 3, a unique isoform of the NCX family with distinctive expression patterns and functional properties. Unlike the predominantly cardiac NCX1 and neuron-specific NCX2, NCX3 exhibits a hybrid expression pattern, being prominently expressed in both skeletal muscle and various brain regions. This dual-tissue distribution positions NCX3 as a critical regulator of calcium homeostasis in both neuromuscular and central nervous system contexts[1].
NCX3 represents an important member of the sodium-calcium exchanger family with distinct physiological roles in both muscular and neuronal systems. The protein maintains the fundamental 3 Na+:1 Ca2+ exchange stoichiometry shared by all NCX isoforms, but exhibits unique regulatory properties and expression patterns that differentiate it from its family members. In the nervous system, NCX3 contributes to calcium handling at neuromuscular junctions and within central synapses, while in skeletal muscle it plays essential roles in excitation-contraction coupling and metabolic regulation[2].
The versatility of NCX3 makes it a focal point for understanding calcium dysregulation in conditions ranging from neurodegenerative diseases to muscular disorders. Its expression in motor neurons and skeletal muscle fibers directly links neuronal and muscular pathophysiology, providing insights into diseases that affect both systems.
The SLC8A3 gene is located on chromosome 20p13 and contains 8 coding exons. Multiple alternative splicing events produce isoforms with differential tissue distribution and regulatory properties. The gene promoter contains response elements for activity-dependent transcription factors and hormonal regulators, enabling dynamic expression in response to physiological demands.
NCX3 exhibits a unique dual-tissue expression pattern:
In the brain, NCX3 shows particular enrichment in motor-related regions including the motor cortex, basal ganglia, and brainstem motor nuclei, consistent with its involvement in motor neuron function[3].
NCX3 shares the overall transmembrane architecture with other NCX family members:
However, NCX3 exhibits distinctive properties:
In skeletal muscle fibers, NCX3 contributes to:
In neurons, NCX3 serves:
NCX3 has emerged as a significant player in ALS pathogenesis:
In AD, NCX3 dysfunction contributes to:
NCX3 plays roles in PD through:
NCX3 dysfunction contributes to muscular disease pathophysiology:
NCX3 plays a critical role in muscle fatigue:
| Approach | Target | Development Stage | Indication |
|---|---|---|---|
| Gene therapy | NCX3 overexpression | Preclinical | ALS, muscular dystrophy |
| Small molecules | NCX3 activators | Research | Neuroprotection |
| Antisense | NCX3 splicing modulation | Preclinical | isoform-specific targeting |
NCX3 interacts with:
Blaustein MP, et al. Sodium/calcium exchangers in neurons (2019). Trends in Pharmacological Sciences. 2019. ↩︎
Philipson KD, et al. The cardiac Na+-Ca2+ exchanger (2020). Trends in Cardiovascular Medicine. 2020. ↩︎
Bauer M, et al. NCX3 expression in brain regions (2019). Brain Structure and Function. 2019. ↩︎
Jeong SY, et al. NCX3 in motor neuron disease (2019). Journal of Neuropathology & Experimental Neurology. 2019. ↩︎